cytogenetics Columbia University-led Study Highlights Bionano Optical Genome Mapping Concordance with Cytogenetics Bionano Genomics called the study, presented this week at the American College for Medical Genetics meeting, an "incredibly important milestone" for the company. Whole-Genome Sequencing Could Replace Cytogenetics in Assessing AML, Myelodysplastic Syndromes The researchers found that sequencing was accurate and could even detect chromosomal changes missed by cytogenetics at almost a similar price. NIH Awards Two SBIR Grants Totaling $3.9M to Phase Genomics The Seattle-based firm has won two grants each worth $1.9 million to develop proximity ligation assays with applications in cytogenetics. Bionano Genomics Q1 Revenues Drop 39 Percent Because of coronavirus-related shutdowns of customer labs, the San Diego-based firm saw decreased revenues in all geographic regions, especially outside the US. Bionano Genomics Reports Preliminary Q1 Revenues of $1.1M Because of COVID-19, the San Diego-based firm said it was unable to ship new instruments and many users were unable to operate their existing ones. Apr 24, 2020 Bionano Genomics Receives Nasdaq Warning Over Low Share Price Apr 8, 2020 Oppenheimer Initiates Coverage of Bionano Genomics at Outperform Nov 7, 2019 Bionano Genomics Q3 Revenues Rise 17 Percent Apr 25, 2019 Impact Lab Group Acquires Toma Advanced Biomedical Assays Services Lab May 31, 2017 Sysmex to Acquire Oxford Gene Technology May 13, 2014 CombiMatrix Prepares New Test Offerings as Reproductive Health Services Drive up Revenues Premium May 7, 2014 CombiMatrix Posts 13 Percent Increase in Q1 Revenues May 6, 2014 PerkinElmer Says It Will Still Sell Signature Genomics Microarrrays, Software Outside US Premium Apr 30, 2014 PerkinElmer to Shutter Signature Genomics Business Apr 22, 2014 New CMA Study Finds Capability to Detect CNVs Has 'Outpaced' Ability to Deduce Their Role in Disease Premium Apr 15, 2014 Affymetrix Provides Fresh Details on FDA Clearance Path for CytoScan Dx Assay Premium Mar 25, 2014 Team Evaluates Impact of Chromosomal Microarray Analysis on Clinical Management Decisions Premium Mar 24, 2014 Chromothripsis Event Touches off Development of Rare Form of Acute Lymphoblastic Leukemia Mar 11, 2014 New Paper Reveals Need for Better Counseling Approaches in Case of Unclear Prenatal CMA Results Premium Mar 4, 2014 OGT Complements Chromosomal Microarray Portfolio with Acquisition of FISH Probe Firm Cytocell Premium Mar 4, 2014 OGT Acquires UK FISH Probe Maker Cytocell Feb 25, 2014 CombiMatrix Credits New ACOG-SFMM Recommendations for Uptick in Prenatal Array Sales Premium Feb 4, 2014 OGT Wins UK NHS Tender to Supply Chromosomal Microarrays to Four 'Significant' Cyto Labs Premium Jan 21, 2014 After Achieving CytoScan Clearance, Affymetrix Looks to Expand Market Presence Abroad and at Home Premium Dec 24, 2013 UK's EACH Project to Deliver Prenatal Array and Karyotyping Test Comparison by 2015 Premium Load More Breaking News Cytosine Base Editor Enables Genome-Wide Genetic Function Screening G42 Healthcare, Seegene to Offer Mobile Molecular Diagnostic Labs in Middle East, North Africa JP Morgan, Cowen Initiate Coverage of Singular Genomics Systems Top Five Articles on GenomeWeb Last Week: Danaher, Becton Dickinson, 23andMe, and More Berry Oncology, Alibaba Health Partner to Offer Early Cancer Screening, Health Services Roche Receives FDA EUA for PCR-Based, Point-of-Care SARS-CoV-2 Test The Scan Renewed Gain-of-Function Worries The New York Times writes that the pandemic is renewing concerns about gain-of-function research. Who's Getting the Patents? A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports. Other Uses CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2. PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.